{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:18:04Z","timestamp":1788200284282,"version":"build-2803163510"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360976"],"award-info":[{"award-number":["82360976"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Ochratoxin A (OTA), a food-borne mycotoxin, has been implicated in hepatotoxicity and potential carcinogenic processes, yet the molecular links between OTA exposure and hepatocellular carcinoma (HCC) remain incompletely understood. This study used an integrated computational workflow to prioritize candidate targets and pathways potentially linking OTA exposure with HCC. OTA-related and HCC-related targets were collected from public databases, intersected, and subjected to functional enrichment analysis. Transcriptomic data from the GSE36376 discovery dataset were analyzed to identify differentially expressed genes, followed by LASSO and SVM-RFE feature selection, immune-cell deconvolution, molecular docking, and molecular dynamics simulation. A total of 214 overlapping OTA-HCC-associated targets were identified and were enriched in pathways related to signal transduction, apoptosis, metabolism, and immune regulation. In GSE36376, 443 differentially expressed genes were identified using p\u2009&lt;\u20090.05 and |log2 fold change|\u2009&gt;\u20091, and overlap analysis yielded 13 shared target genes. Five candidate targets, CYP3A4, KIFC1, AKR1C3, CA2, and TTR, were further prioritized. KIFC1 and AKR1C3 were upregulated in HCC samples, whereas CYP3A4, CA2, and TTR were downregulated. These genes showed apparent discriminatory ability within the discovery dataset, with AUC values ranging from 0.866 to 0.958. Molecular docking predicted favorable OTA-target interactions, with docking energies ranging from \u22127.4 to \u221210.8 kcal\/mol. CYP3A4 showed the lowest predicted docking energy (\u221210.8 kcal\/mol) and was further evaluated by molecular dynamics simulation, with a protein-fitted OTA RMSD of 1.435\u2009\u00b1\u20090.097 nm and complex Rg of 2.308\u2009\u00b1\u20090.010 nm during the equilibrated 20\u2013100 ns trajectory. Overall, this study provides a reproducible hypothesis-generating framework for exploring potential metabolic, genomic-instability-related, and immune-microenvironment links between OTA exposure and HCC. Future validation in independent datasets and experimental models will be important to further assess the biological relevance of these candidate targets and pathways.<\/jats:p>","DOI":"10.1371\/journal.pone.0357594","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:29:13Z","timestamp":1788197353000},"page":"e0357594","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated computational analysis prioritizes candidate targets and pathways linking ochratoxin A exposure to hepatocellular carcinoma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4125-3323","authenticated-orcid":true,"given":"Shili","family":"Yang","sequence":"first","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiquan","family":"Liu","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Kou","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Lai","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Xu","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1150-727X","authenticated-orcid":true,"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine","place":["Guiyang, Guizhou Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"12","key":"pone.0357594.ref001","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"AG Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"8004","key":"pone.0357594.ref002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-024-07054-3","article-title":"Deep whole-genome analysis of 494 hepatocellular carcinomas","volume":"627","author":"L Chen","year":"2024","journal-title":"Nature"},{"issue":"1","key":"pone.0357594.ref003","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12967-025-06517-z","article-title":"Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach","volume":"23","author":"Y Hong","year":"2025","journal-title":"J Transl Med"},{"issue":"1","key":"pone.0357594.ref004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2005.10.106","article-title":"Toxicokinetics and toxicodynamics of ochratoxin A, an update","volume":"159","author":"D Ringot","year":"2006","journal-title":"Chem Biol Interact"},{"issue":"4","key":"pone.0357594.ref005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/toxins8040111","article-title":"Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level","volume":"8","author":"T K\u0151szegi","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"20","key":"pone.0357594.ref006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16203473","article-title":"Ochratoxin A and its role in cancer development: a comprehensive review","volume":"16","author":"M Wi\u0119ckowska","year":"2024","journal-title":"Cancers"},{"key":"pone.0357594.ref007","doi-asserted-by":"crossref","first-page":"1225697","DOI":"10.3389\/fphar.2023.1225697","article-title":"Assessing network-based methods in the context of system toxicology","volume":"14","author":"J Valls-Margarit","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"pone.0357594.ref008","first-page":"14","article-title":"Introduction to Machine Learning, Neural Networks, and Deep Learning","volume":"9","author":"RY Choi","year":"2020","journal-title":"Translational Vision Science & Technology"},{"key":"pone.0357594.ref009","doi-asserted-by":"crossref","first-page":"662135","DOI":"10.3389\/fonc.2021.662135","article-title":"Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity","volume":"11","author":"A \u00d6zkan","year":"2021","journal-title":"Front Oncol"},{"key":"pone.0357594.ref010","doi-asserted-by":"crossref","first-page":"799651","DOI":"10.3389\/fmolb.2021.799651","article-title":"Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma","volume":"8","author":"D Li","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"3","key":"pone.0357594.ref011","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.18632\/aging.202380","article-title":"Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma","volume":"13","author":"P Zhu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"pone.0357594.ref012","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/carcin\/bgx148","article-title":"Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma","volume":"39","author":"C Zhang","year":"2018","journal-title":"Carcinogenesis"},{"issue":"6","key":"pone.0357594.ref013","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/ijms21062075","article-title":"Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer\u2019s Disease","volume":"21","author":"T Gi\u00e3o","year":"2020","journal-title":"Int J Mol Sci"},{"key":"pone.0357594.ref014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"MJ Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"16","key":"pone.0357594.ref015","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"D Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"issue":"3","key":"pone.0357594.ref016","doi-asserted-by":"crossref","first-page":"905","DOI":"10.62347\/FSIQ3194","article-title":"TNFAIP1 suppresses hepatocellular carcinoma progression via the PXR\/CYP3A4 signaling axis","volume":"16","author":"Q Nie","year":"2026","journal-title":"Am J Cancer Res"},{"issue":"12","key":"pone.0357594.ref017","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ans.14458","article-title":"Clinical significance of serum transthyretin level in patients with hepatocellular carcinoma","volume":"88","author":"T Shimura","year":"2018","journal-title":"ANZ J Surg"},{"issue":"31","key":"pone.0357594.ref018","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/s41388-022-02379-7","article-title":"AKR1C3 regulated by NRF2\/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma","volume":"41","author":"D Pan","year":"2022","journal-title":"Oncogene"},{"key":"pone.0357594.ref019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.apha.2018.04.007","article-title":"Cytochrome P450 in Pharmacogenetics: An Update","volume":"83","author":"A Tornio","year":"2018","journal-title":"Adv Pharmacol"},{"issue":"6","key":"pone.0357594.ref020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","author":"PB Danielson","year":"2002","journal-title":"Curr Drug Metab"},{"issue":"3","key":"pone.0357594.ref021","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.2014.129","article-title":"Functional gene variants of CYP3A4","volume":"96","author":"AN Werk","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"pone.0357594.ref022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1247\/csf.12014","article-title":"KIFC1 is essential for bipolar spindle formation and genomic stability in the primary human fibroblast IMR-90 cell","volume":"38","author":"N Kim","year":"2013","journal-title":"Cell Struct Funct"},{"issue":"30","key":"pone.0357594.ref023","doi-asserted-by":"crossref","first-page":"48656","DOI":"10.18632\/oncotarget.8799","article-title":"KIFC1: a promising chemotherapy target for cancer treatment?","volume":"7","author":"Y-X Xiao","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0357594.ref024","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.toxlet.2025.06.015","article-title":"Arsenic enhances endoplasmic reticulum stress via YTHDC1\/AKR1C3 aix to promote the malignant transformation of human urothelial cells","volume":"410","author":"C Chen","year":"2025","journal-title":"Toxicol Lett"},{"key":"pone.0357594.ref025","doi-asserted-by":"crossref","first-page":"1378292","DOI":"10.3389\/fphar.2024.1378292","article-title":"AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies","volume":"15","author":"M Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"pone.0357594.ref026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1107\/S2052252517017626","article-title":"Active-site solvent replenishment observed during human carbonic anhydrase II catalysis","author":"JK Kim","year":"2018","journal-title":"Iucrj"},{"issue":"1","key":"pone.0357594.ref027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12964-019-0478-4","article-title":"Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment","volume":"17","author":"DA Annan","year":"2019","journal-title":"Cell Commun Signal"},{"issue":"6","key":"pone.0357594.ref028","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.pan.2024.07.012","article-title":"Preoperative level of serum transthyretin as a novel biomarker predicting survival in resected pancreatic ductal adenocarcinoma with neoadjuvant therapy","volume":"24","author":"Y Nanno","year":"2024","journal-title":"Pancreatology"},{"issue":"2","key":"pone.0357594.ref029","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ccell.2025.01.001","article-title":"Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer","volume":"43","author":"X Guo","year":"2025","journal-title":"Cancer Cell"},{"issue":"3","key":"pone.0357594.ref030","first-page":"287","article-title":"Immune Regulatory Networks and Therapy of \u03b3\u03b4 T Cells in Liver Cancer: Recent Trends and Advancements","volume":"12","author":"K-L Yin","year":"2024","journal-title":"J Clin Transl Hepatol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:29:18Z","timestamp":1788197358000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357594"}},"subtitle":[],"editor":[{"given":"Serkan","family":"Y\u0131lmaz","sequence":"first","affiliation":[{"name":"Ankara University: Ankara Universitesi","place":["T\u00dcRKIYE"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357594","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}